FDA Opioid Review Adds Another Push For Advisory Committee Overhaul
Executive Summary
External report on the US FDA’s response to the opioid epidemic includes detailed recommendations for enhancements to the advisory committee review process. That dovetails with the agency’s ongoing look at how best to use the expert panels.